Description
EXERCISING OPTION YEAR 3 10/01/25 -09/30/26 FECAL OCCULT BLOOD TESTING USING VENTANA/ROCHE'S HISTOLOGY EQUIPMENT/MACHINE/INSTRUMENTS.
Base award description: FECAL OCCULT BLOOD TESTING USING VENTANA/ROCHE'S HISTOLOGY EQUIPMENT/MACHINE/INSTRUMENTS.
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$44,877= $44,877
- Mod P000012023-09-15+$44,877= $89,754
- Mod P000022024-10-01+$44,877= $134,631
- Mod P000032025-10-01+$44,877= $179,508
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$44,877 | $44,877 | FECAL OCCULT BLOOD TESTING USING VENTANA/ROCHE'S HISTOLOGY EQUIPMENT/MACHINE/INSTRUMENTS. |
| Mod P00001· EXERCISE AN OPTION | 2023-09-15 | +$44,877 | $89,754 | EXERCISING OPTION YEAR 1 (SYSTEM SAYS TO USE POP START DATE OF BASE YEAR 10/01/2022, EVEN THOUGH THIS IS OY1 W… |
| Mod P00002· EXERCISE AN OPTION | 2024-10-01 | +$44,877 | $134,631 | EXERCISING OPTION YEAR 2 10/01/24 -09/30/25 FECAL OCCULT BLOOD TESTING USING VENTANA/ROCHE'S HISTOLOGY EQUIPME… |
| Mod P00003· FUNDING ONLY ACTION | 2025-10-01 | +$44,877 | $179,508 | EXERCISING OPTION YEAR 3 10/01/25 -09/30/26 FECAL OCCULT BLOOD TESTING USING VENTANA/ROCHE'S HISTOLOGY EQUIPME… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI STNDUK44ENE8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0941 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $25,596 | FY2026 |
| 36C24726N0361 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q403 · MEDICAL- EVALUATION/SCREENING | $90,000 | FY2026 |
| 36C25726N0497 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $30,770 | FY2026 |
| 36C24526N0729 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $90,000 | FY2026 |
| 36C24526A0052 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $0 | FY2026 |
| 36C25726N0398 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $68,049 | FY2026 |
Other recipients under 6630 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25026N0679 | NUAIRE INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $18,817 | FY2026 |
| 36C25026A0039 | BECKMAN COULTER, INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $0 | FY2026 |
| 36C25026N0566 | BECKMAN COULTER, INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $41,685 | FY2026 |
| 36C25026N0495 | BECKMAN COULTER, INC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $138,891 | FY2026 |
| 36C25026N0446 | QUIDELORTHO SALES COMPANY, LLC | 250-NETWORK CONTRACT OFFICE 10 (36C250) | $45,216 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25023F0062_3600_36F79720D0016_3600 · retrieved 2026-09-26.